BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/14/2025 10:33:15 AM | Browse: 59 | Download: 72
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 100342
Country Australia
Received
2024-08-14 00:28
Peer-Review Started
2024-08-14 00:28
To Make the First Decision
Return for Revision
2024-11-11 07:28
Revised
2024-11-20 05:47
Second Decision
2024-12-04 02:43
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2024-12-04 07:38
Articles in Press
2024-12-04 07:38
Publication Fee Transferred
Edit the Manuscript by Language Editor
2024-12-11 11:25
Typeset the Manuscript
2025-01-22 03:50
Publish the Manuscript Online
2025-02-14 10:33
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Editorial
Article Title Resveratrol and pancreatic cancers: Questions and future perspectives
Manuscript Source Invited Manuscript
All Author List Olga A Sukocheva
ORCID
Author(s) ORCID Number
Olga A Sukocheva http://orcid.org/0000-0003-1041-3311
Funding Agency and Grant Number
Corresponding Author Olga A Sukocheva, PhD, Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Port Road, Adelaide 5000, South Australia, Australia. olga.sukocheva@sa.gov.au
Key Words Pancreatic cancer; Resveratrol; Cancer-associated fibroblasts; Tumor microenvironment; Antioxidant; Immune senescence
Core Tip A promising new direction for the treatment of pancreatic cancer has been investigated and reported by Jiang et al. Using immunohistochemistry, authors assessed pancreatic cancer tissues and detected a presence of senescent cancer-associated fibroblasts (CAFs) in the tumor microenvironment. Following this, authors observed the ability of the natural polyphenolic compound resveratrol to reverse the senescent CAF phenotype and inhibit pancreatic cancer progression in vitro and in vivo. This editorial letter accents important aspects of the original article and discusses future perspectives of resveratrol-including therapy.
Publish Date 2025-02-14 10:33
Citation <p>Sukocheva OA. Resveratrol and pancreatic cancers: Questions and future perspectives. <i>World J Gastrointest Oncol</i> 2025; 17(3): 100342</p>
URL https://www.wjgnet.com/1948-5204/full/v17/i3/100342.htm
DOI https://dx.doi.org/10.4251/wjgo.v17.i3.100342
Full Article (PDF) WJGO-17-100342-with-cover.pdf
Manuscript File 100342_Auto_Edited_013901.docx
Answering Reviewers 100342-answering-reviewers.pdf
Audio Core Tip 100342-audio.mp3
Conflict-of-Interest Disclosure Form 100342-conflict-of-interest-statement.pdf
Copyright License Agreement 100342-copyright-assignment.pdf
Peer-review Report 100342-peer-reviews.pdf
Scientific Misconduct Check 100342-scientific-misconduct-check.png
Scientific Editor Work List 100342-scientific-editor-work-list.pdf
CrossCheck Report 100342-crosscheck-report.png
CrossCheck Report 100342-crosscheck-report.pdf